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Summary
The Sbi protein of Staphylococcus aureus comprises
two IgG-binding domains similar to those of protein A
and a region that triggers the activation of comple-
ment C3. Sbi is expressed on the cell surface but its
C-terminal domain lacks motifs associated with wall
or membrane anchoring of proteins in Gram-positive
bacteria. Cell-associated Sbi fractionates with the
cytoplasmic membrane and is not solubilized during
protoplast formation. S. aureus expressing Sbi trun-
cates of the C-terminal Y domain allowed identifica-
tion of residues that are required for association of
Sbi with the membrane. Recombinant Sbi bound to
purified cytoplasmic membrane material in vitro and
to purified lipoteichoic acid. This explains how Sbi
partitions with the membrane in fractionation experi-
ments yet is partially exposed on the cell surface. An
LTA-defective mutant of S. aureus had reduced levels
of Sbi in the cytoplasmic membrane.
Introduction
Staphylococcus aureus permanently colonizes the moist
squamous epithelium of the anterior nares of approxi-
mately 20% of the population while the remainder carry
the organism intermittently (Williams, 1963; Peacock
et al., 2001). Colonization is an established risk factor for
development of infection both in the hospital and in the
community (Lowy, 1998). S. aureus can cause a variety of
infections ranging from superficial skin lesions such as
boils and abscesses to invasive and potentially life-
threatening infections such as osteomyelitis, septic arthri-
tis and endocarditis (Petti and Fowler, 2003; Fowler et al.,
2005).
The ability of S. aureus to cause infections is in part due
to proteins that are anchored to the cell surface and to
those that are secreted into the medium. Among the latter
are cytolytic toxins, enzymes and proteins with immune
evasion functions that interfere with neutrophil migration
and complement fixation (Foster, 2005). While a major
function of surface-anchored proteins is to act as adhes-
ins and invasins (Foster, 2005), it is also clear that several
can also help the bacterium evade innate immune
responses. Thus protein A binds to the Fc region of IgG
and coats the cell with antibody that cannot be recognized
by Fc receptors on neutrophils and cannot catalyse
complement fixation. Clumping factor A binds fibrinogen
and fibrin (McDevitt et al., 1997) but it can also capture
and activate the complement regulatory protease factor I
which results in enhanced degradation of C3b (Cunnion
et al., 2004; Hair et al., 2008).
Proteins can be anchored to the cell envelope of Gram-
positive bacteria by several mechanisms (Cabanes et al.,
2002). (i) Covalent linkage to cell wall peptidoglycan
occurs by the action of sortase on the LPXTG motif that is
part of a C-terminal wall-anchoring domain (Mazmanian
et al., 2001). The sorting signal also comprises a hydro-
phobic membrane-spanning domain followed at the
extreme C-terminus by positively charged residues. (ii)
Lipoproteins are possibly anchored to the outer face of the
cytoplasmic membrane (Inouye et al., 1977; Bubeck
Wardenburg et al., 2006). The signal peptide is typically
shorter than that of proteins that are secreted into the
medium and is followed by a cysteine residue. Lipoprotein
diacylglycerol transferase catalyses transfer of diacylgly-
cerol from phosphatidylglycerol in the outer face of
the membrane to the sulphydryl moiety of the cysteine
followed by cleavage of the signal peptide by signal
peptidase II (Tokunaga et al., 1982; Choi et al., 1986;
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Gan et al., 1993). (iii) Proteins may be anchored non-
covalently to the cell wall components peptidoglycan and
teichoic acids. Internalin B (InlB) of Listeria monocytoge-
nes has C-terminal ‘GW’ repeat domains of ~ 80 residues
that bind to lipoteichoic acid (LTA) (Jonquieres et al.,
1999). Thus InlB is associated with the cytoplasmic mem-
brane in cell fractionation experiments but can also occur
extracellularly (Braun et al., 1997). Furthermore, cell-
bound InlB can be displaced by soluble LTA and by highly
negatively charged heparin sulphate proteoglycan
(Jonquieres et al., 1999). Autolysins such as Alt from
S. aureus and AtlE from Staphylococcus epidermidis are
also attached to the cell envelope via GW repeats (Oshida
et al., 1995; Heilmann et al., 1997). (iv) The extracellular
adherence protein Eap (also known as Map) has repeated
domains that can bind to several different ligands (Cha-
vakis et al., 2002). The protein can also bind to the
bacterial cell surface by an unknown mechanism and
promote attachment to and invasion of mammalian cells,
most likely by binding to fibronectin and forming a bridge
to the a5b1 integrin (Harraghy et al., 2003; Hussain et al.,
2008).
The second binding protein for immunoglobulins (Sbi)
comprises four N-terminal ligand-binding repeats. Its
C-terminus comprises the proline-rich region Wr and the
tyrosine-rich region Y that is assumed to be involved in
Sbi association with the cell envelope (Fig. 1; Zhang
et al., 1998). The first two N-terminal repeats (D1 and D2)
have sequence similarity to the IgG-binding domains of
protein A. Indeed the predicted structures show that resi-
dues on the faces of helices I and II of Spa and Sbi are
conserved, allowing Sbi to bind to IgG in a similar fashion
to the archetypal LPXTG-anchored immune evasion
protein. Domains D3 and D4 are also separately folded
and contribute to the elongated structure of the protein
(Burman et al., 2008; Upadhyay et al., 2008). They bind to
complement protein C3. It has been argued that binding to
and promoting the conversion of C3 to C3b would only be
an effective immune evasion mechanism if the protein
were extracellular (Burman et al., 2008).
Previously we reported a detailed and systematic
analysis of the cellular location of Sbi (Smith et al., 2011).
By analysing mutants lacking Sbi and protein A we were
able to demonstrate that Sbi occurs both extracellularly
and bound to the cell envelope and that both contribute
to immune evasion. By expressing truncated Sbi in
S. aureus and using purified recombinant Sbi we show
that the C-terminal Y domain is required for attachment to
the membrane. This is likely to be mediated by its inter-
action with lipoteichoic acid.
Results
Surface expression of Sbi D3D4 ligand-binding domains
Previously we reported the surface exposure of the IgG
binding D1D2 domains of Sbi (Smith et al., 2011). In order
to determine if the C3-binding domains of Sbi were
exposed on the cell surface whole cells were immobilized
on membranes and probed with rabbit antibodies raised
against the non-IgG binding D3D4 domains of Sbi. Cells
expressing wild-type Sbi could bind antibodies via
domains D1 and D2 by a non-immune reaction as well as
by a specific immune reaction with domains D3 and D4.
The same reactivity was seen with cells expressing wild-
type Sbi from the chromosomal gene and when induced
from pRMC2sbi + (Fig. 2). In contrast cells expressing a
mutant of pRMC2sbi+ which expressed a truncate that
Fig. 1. Schematic diagrams of Sbi and Spa. The upper figure is Sbi and the lower is Spa. S, signal sequence; D1D2, Sbi IgG-binding
domains that have sequence similarity to the IgG-binding domains of Spa (E, D, A, B, C); D3D4, Sbi complement factor C3-binding domains;
Wr and Xr, proline-rich C-terminal domains; Y, C-terminal domain; LPXTG, wall-anchoring motif; M, transmembrane domain and positively
charged C-terminus. Spa ligands are indicated.
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lacked the IgG binding D1D2 domains reacted 16- to
32-fold less. Given that D1 and D2 can each bind to a
single Fc region each whereas D3D4 most likely has
several epitopes for polyclonal IgG Fab it is possible that
the majority of D3D4 are buried within the cell wall and are
not exposed on the cell surface.
Sbi binding to the cytoplasmic membrane
To address the importance of the C-terminal domain of Sbi
in membrane anchoring, three maltose-binding protein
(MBP) fusion proteins were constructed (Fig. 3A). These
comprised the entire Sbi protein (residues 41–436), the
N-terminal ligand-binding domains (residues 41–253) and
the C-terminal domains Wr and Y (residues 253–436). The
proteins were expressed in Escherichia coli and purified by
affinity chromatography. Their purity and integrity were
verified by SDS-PAGE (Fig. 3B) and Western blotting with
anti-MBP antiserum (Fig. 3C).
Cytoplasmic membrane material purified from S. aureus
Newman Spa- Sbi- was incubated in microtitre plates
and coating of the surface was verified with antibodies
recognizing the integral membrane protein EbpS (data
not shown). The membranes were incubated with
MBP–Sbi41–436 and MBP–Sbi254–436 which were able to bind
in a dose-dependent and saturable manner with half
maxima of 0.54  0.1 nM and 0.57  0.1 nM, respec-
tively, while MBP–Sbi41–253 and the MBP control were
unable to bind (Fig. 3D). These results indicate that the
C-terminal WrY domain of Sbi binds to purified cytoplasmic
membrane mimicking precisely the results seen with frac-
tionated S. aureus cells expressing Sbi truncates.
Recombinant Sbi binds to whole cells and fractionates
with the cytoplasmic membrane
Recombinant MBP–Sbi binds to purified cytoplasmic
membrane material with high affinity. To address whether
this mode of association is similar to that of Sbi expressed
by S. aureus, recombinant proteins MBP–Sbi41–436,
MBP–Sbi41–253 and MBP–Sbi254–436 were separately incu-
bated with whole cells of Newman spa sbi. MBP–Sbi41–436
and MBP–Sbi254–436 both bound to whole cells dose-
dependently and saturably with similar half-maximal
binding concentrations (0.55  0.03 nM and 0.57 
0.02 nM respectively) (Fig. 4A). Binding of recombinant
MBP–Sbi41–436, MBP–Sbi41–253, MBP–Sbi254–436 and MBP to
whole cells of strain Newman Spa- Sbi- was also investi-
gated by flow cytometry. Recombinant Sbi derivatives were
separately incubated with whole cells of Newman Spa-
Sbi- and binding was detected with monoclonal mouse
anti-MBP followed by FITC-labelled rabbit anti-mouse IgG.
MBP–Sbi41–436 and MBP–Sbi254–436 both bound to whole
cells confirming the enzyme-linked immunosorbent assay
(ELISA) result (Fig. 4B and C).
In order to determine if recombinant Sbi that bound to the
bacterial cells fractionated with the cell wall or membranes
during protoplast formation, and to determine if a receptor
for Sbi is exposed on the cell surface, Newman Spa- Sbi-
was incubated with MBP–Sbi41–436 and MBP–Sbi254–436,
washed and then fractionated to isolate the cytoplasmic
membrane. Figure 4D shows the purified cytoplasmic
membrane fraction probed with HRP-conjugated anti-MBP
antiserum. The ~ 86 kDa band present in lane 3 corre-
sponds to recombinant MBP–Sbi41–436 while the ~ 63 kDa
band in lane 4 corresponds to recombinant MBP–Sbi254–436
(Fig. 4D). These data show that a receptor for the C-
terminal domain of Sbi is exposed on the cell surface and
yet the added recombinant protein is associated with the
membrane following fractionation of protoplasts
Sbi binds to lipoteichoic acid
The C-terminal region of Sbi has neither a sequence of
hydrophobic residues sufficient to span the cytoplasmic
membrane typical of integral or membrane-spanning pro-
teins nor a lipoprotein consensus sequence that could be
involved in anchoring the protein to the cytoplasmic mem-
brane, raising the possibility that the association of Sbi with
the cytoplasmic membrane could be due to binding to a
membrane-associated component. Lipoteichoic acid (LTA)
is an anionic polymer linked to a glycolipid anchor in the
outer face of the cytoplasmic membrane and with a poly(g-
lycerophosphate) chain that extends across the cell wall
(Neuhaus and Baddiley, 2003). LTA remains associated
with the protoplast after removal of the cell wall peptidogly-
can by lysostaphin (Neuhaus and Baddiley, 2003). To
determine if LTA could be the target for the C-terminal WrY
domain of Sbi, wells of microtitre plates were coated
with a constant amount of purified S. aureus LTA and
incubated with increasing concentrations of recombin-
ant MBP–Sbi41–436, MBP–Sbi41–253 and MBP–Sbi254–436.
Fig. 2. Surface expression of Sbi domains D3D4. Serial dilutions
of cells were applied to a nitrocellulose membrane and probed with
rabbit anti-Sbi D3D4WrY IgG followed by HRP-conjugated goat
anti-rabbit IgG.
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Fig. 3. Binding of MBP–Sbi41–436, MBP–Sbi41–253 and MBP–Sbi254–436 to purified cytoplasmic membrane.
A. Schematic diagram of Sbi showing the residues present in each recombinant MBP-tagged protein.
B. Coomassie stain of an SDS-PAGE gel of MBP–Sbi recombinant proteins.
C. Western immunoblot of MBP–Sbi recombinant proteins probed with HRP-conjugated anti-MBP IgG.
D. Binding of MBP–Sbi41–436, MBP–Sbi254–436 MBP–Sbi41–253 and MBP to wells coated with cytoplasmic membrane material isolated from
Newman Spa- Sbi- cells. Recombinant protein binding was detected with HRP-conjugated anti-MBP IgG. Binding assay was preformed n = 3
times with similar results. The graph shown is a representative of one experiment with each point plot representing the average of duplicate
wells.
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Proteins containing the C-terminal domain WrY (Sbi41–436
and Sbi254–436) were able to bind LTA in a dose-dependent
and saturable manner with half maximal concentrations of
0.86  0.2 nM and 0.84  0.2 nM respectively (Fig. 5A).
Furthermore, pre-incubation of Sbi with different concen-
trations of S. aureus LTA inhibited binding to immobilized
LTA and to purified cytoplasmic membranes in a dose-
dependent manner (Fig. 5B and C).
To investigate the specificity of the interaction between
Sbi and LTA, MBP–Sbi was pre-incubated with different
concentrations of heparin sulphate, an anionic glycosami-
noglycan which consists of a repeating disaccharide unit
of glucosamine and uronic acid residues and which
occurs on the surface of mammalian cells (Li and Vlo-
davsky, 2009). Heparin sulphate (HS) was able to dis-
place InlB from the surface of L. monocytogenes but was
not able to inhibit the interaction of MBP–Sbi with immo-
bilized LTA or purified cytoplasmic membrane material
(Fig. 5B and C), suggesting that the interaction between
LTA and Sbi is specific and not simply due to the positively
Fig. 4. Binding of MBP–Sbi41–436, MBP–Sbi41–253 and MBP–Sbi254–436 to whole cells of Newman Spa- Sbi-.
A. Binding of MBP–Sbi41–436, MBP–Sbi254–436 MBP–Sbi41–253 and MBP to wells coated with whole Newman Spa- Sbi- cells. Recombinant protein
binding was detected with HRP-conjugated anti-MBP IgG. Binding assay was preformed n = 3 times with similar results. The graph shown is a
representative of one experiment with each plot in the graph representing the average of duplicate wells.
B. Washed whole cells of Newman Spa- Sbi- were incubated with 0.5 mM MBP–Sbi41–436, MBP–Sbi254–436, MBP–Sbi41–253 and MBP followed by
mouse anti-MBP antiserum and FITC-labelled rabbit anti-mouse IgG. Fluorescence intensity was measured by flow cytometry. The assay was
preformed n = 3 times. Each plot on the graph represents the average value for all three replicas. Error bars show the standard deviation.
C. A representative flow cytometry trace of recombinant Sbi derivatives binding to Newman Spa- Sbi-.
D. Recombinant MBP–Sbi41–436, MBP–Sbi254–436 MBP–Sbi41–253 and MBP were incubated with whole cells of Newman Spa- Sbi- and
fractionated. Cytoplasmic membrane fractions were analysed by Western blotting with HRP-conjugated anti-MBP IgG or rabbit anti-EbpS IgG
followed by HRP-conjugated protein A. All immunoblotting experiments were repeated n = 3 times.
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charged protein binding to negatively charged residues in
surface polymers.
Can Sbi bind to purified cell wall?
The cell wall contains wall teichoic acid, a polymer of
ribitol phosphate that is covalently anchored to the pepti-
doglycan (Neuhaus and Baddiley, 2003; Xia et al., 2010)
as well as covalently anchored wall-associated proteins
such as ClfA and Spa. The cell wall fraction of S. aureus
Newman Spa- Sbi- was purified following disruption of the
cells by mechanical shearing and by boiling with deter-
gent to solubilize the cytoplasmic membrane.
The coating affinity and purity of the cell wall fraction
was assessed by ELISA using (i) polyclonal anti-ClfA anti-
bodies and (ii) polyclonal anti-EbpS antibodies, with
maximum absorbencies at saturation 0.76 and 0.22
respectively. This showed that the wall fraction bound to
the ELISA wells efficiently and that the level of contami-
nation with membrane was low. MBP–Sbi41–436 and
MBP–Sbi254–436 was added to the cell wall-coated ELISA
wells but did not bind detectably. This shows that Sbi
cannot bind to the purified cell wall fraction (Fig. 5D).
Displacement of Sbi from purified cytoplasmic
membranes by soluble LTA
In order to determine if soluble LTA could displace Sbi
from the membrane of S. aureus cells, purified cytoplas-
mic membranes of the Sbi+ strain Newman Spa- were
incubated with different concentrations of LTA. Some Sbi
was displaced into the supernatant in a concentration-
dependent manner while the majority remained associ-
ated with the membrane (Fig. 6A). This indicates that Sbi
is attached to the membrane with high affinity at least in
part by binding to LTA and suggests the possibility of a
second ligand.
Detection of Sbi–LTA interaction by Far Western blotting
The experiment described above shows that recombinant
Sbi can bind to LTA. In order to determine if Sbi expressed
by S. aureus binds LTA a Far Western blotting approach
was taken. The membrane fraction of S. aureus Newman
Spa- Sbi- lacking the ability to express the IgG-binding
proteins Spa and Sbi from chromosomal genes but
expressing SbiDD1D2 from pRMC2 was purified. The mem-
Fig. 5. Interaction of MBP–Sbi with LTA.
A. Binding of MBP–Sbi41–436, MBP–Sbi254–436 MBP–Sbi41–253 and MBP to LTA-coated wells.
B and C. (B) Inhibition of binding of MBP–Sbi41–436 and MBP–Sbi254–436 to LTA and (C) to the purified cytoplasmic membrane fraction from
S. aureus Newman Spa- Sbi-. Recombinant proteins were pre-incubated with increasing concentrations of either S. aureus LTA or heparin
sulphate (0–200 mg ml-1) before being added to coated microtitre plates.
D. Binding of MBP–Sbi proteins to purified cell wall-coated wells. In each assay recombinant protein binding was detected with
HRP-conjugated anti-MBP IgG. Each assay was preformed n = 3 times with similar results. The graphs shown are representatives of one
experiment with each plot in the graph representing the average of triplicate wells.
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brane fraction was separated by SDS-PAGE, transferred
to a nitrocellulose membrane and probed with LTA fol-
lowed by a mouse monoclonal antibody to LTA and HRP-
conjugated rabbit anti-mouse IgG. The reactive band at
~ 35 kDa corresponds to SbiDD1D2 demonstrating that Sbi
expressed from S. aureus binds LTA (Fig. 6B). An immu-
noreactive band of 17–24 kDa was detected in both
samples which presumably corresponds to LTA that is
present in the membrane fraction (Fig. 7B). The Far
Western blot was subsequently stripped, probed with
anti-Sbi serum and overlaid on the original blot (Fig. 6B).
A reactive band at ~ 35 kDa was detected which corre-
sponds to SbiDD1D2 demonstrating that it is Sbi expressed
from S. aureus which binds LTA in the Far Western blot.
Fig. 6. Analysis of the Sbi–LTA interaction.
A. Displacement of Sbi from the cytoplasmic membrane by soluble LTA. Newman Spa- cytoplasmic membrane was incubated with increasing
amounts of S. aureus LTA (0–400 mg ml-1). Sbi bound to the cytoplasmic membrane or released into the supernatant was detected using rabbit
anti-Sbi D3D4WrY IgG followed by HRP-conjugated goat anti-rabbit IgG.
B. Far Western blotting of S. aureus cytoplasmic membrane fractions with LTA. Newman Spa- Sbi- and Newman Spa- Sbi- (pRMC2-sbiDD1D2)
cytoplasmic membrane material was fractionated by SDS-PAGE, transferred to a nitrocellulose membrane incubated with purified LTA and
bound LTA was detected with anti-LTA monoclonal antibody followed by HRP-linked rabbit anti-mouse IgG. All immunoblotting experiments
were repeated n = 3 times.
Fig. 7. Sbi cellular location in LTA-negative strains.
A. Whole-cell lysate fractions of RN4220 Spa-, 4S5 and 4S5 (pCN34-ltaS) analysed by Western immunoblotting with monoclonal mouse
anti-LTA antibodies followed by HRP-conjugated rabbit anti-mouse IgG.
B. Cytoplasmic membrane and culture supernatant fractions of RN4220 Spa-, 4S5 and 4S5 (pCN34-ltaS) analysed by Western
immunoblotting with rabbit anti-Sbi D3D4WrY IgG and HRP-conjugated goat anti-rabbit IgG (i and ii) and rabbit anti-EbpS IgG followed by
HRP-conjugated goat anti-rabbit IgG (iii). Blots shown are representative of three independent experiments. Densitometric analysis was
carried out using ImageJ software. Integrated band densities were measured with correction of background. Values given are the mean  the
standard deviation of n = 3 experiments
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An LTA defective mutant has decreased levels of Sbi in
the cytoplasmic membrane
Staphylococcus aureus mutants that lack LTA can only
grow under osmotically stabilizing conditions or by the
acquisition of compensatory mutations (Oku et al., 2009;
Corrigan et al., 2011). The RN4220 Spa--derived LTA-
deficient strain 4S5 contains a complete deletion of the
LTA synthase gene ltaS and has acquired two additional
mutations that permit this strain to grow and divide in the
absence of LTA similar to the wild type (Corrigan et al.,
2011). To assess the role of LTA in the localization of Sbi
to the cell membrane, cytoplasmic membrane and culture
supernatant fractions of wild-type RN4220 Spa- and 4S5
cells grown to mid-exponential phase were isolated and
analysed by SDS-PAGE and Western immunoblotting
using the rabbit anti-Sbi D3D4WrY serum. An immunore-
active band of ~ 50 kDa was detected in the membrane
and supernatant fractions of both the wild-type and LTA-
negative strain [Fig. 7B(i)]. However, densitometric analy-
sis of band intensity indicated that strain 4S5 exhibited
3.4  0.4-fold lower levels of Sbi in its cytoplasmic mem-
brane but contained a 1.8  0.2-fold higher level of Sbi in
the supernatant fraction as compared with the wild-type
strain [Fig. 7B(ii)].
To confirm the role of LTA in Sbi localization and to rule
out any involvement of the suppressor mutations present in
4S5, the complementation vector pCN34-ltaS (Corrigan
et al., 2011), which expresses ltaS from its native promoter,
was electroporated into 4S5. This resulted in the restora-
tion of LTAsynthesis as judged by Western immunoblotting
(Fig. 7A). Complementation with pCN34-ltaS also restored
Sbi expression in the cytoplasmic membrane to wild-type
levels (Fig. 7B). This shows that the suppressor mutations
are not responsible for the reduction in Sbi in the mem-
brane fraction and directly implicates LTA in attaching Sbi
to the cell envelope. Furthermore, the level of the integral
membrane protein EbpS in the cytoplasmic membrane
of all strains was the same. This indicates that the inhibition
of LTA expression does not affect another membrane-
associated protein [Fig. 7B(iii)].
Association of Sbi with the membrane by its C-terminal
Y domain
It seemed likely that the C-terminal domain Y is involved in
attaching Sbi to the cytoplasmic membrane. To test this,
an MBP-fusion protein was constructed that comprised
the C-terminal Y domain (residues 303–436) (Fig. 3A).
The protein was expressed in E. coli and purified by affin-
ity chromatography. The protein’s purity and integrity were
verified by SDS-PAGE and Western blotting with anti-
MBP serum (Fig. 8A).
Cytoplasmic membrane material purified from S. aureus
Newman Spa- Sbi- was incubated in microtitre plates and
coating of the surface verified with antibodies recognizing
the integral membrane protein EbpS (data not shown). The
membranes were incubated with MBP–Sbi303–436 which
was able to bind in a dose-dependent and saturable
manner with half maxima of 0.5  0.04 nM while the MBP
control was unable to bind (Fig. 8B). These results indicate
that the C-terminal Y domain of Sbi binds to purified
cytoplasmic membrane. MBP–Sbi303–436 also bound puri-
fied LTA in a dose-dependent and saturable manner with
half maxima of 1  0.15 nM (Fig. 8C).
To localize the residues involved, the full-length sbi gene
and a series of deletions were cloned into the expression
vector pRMC2 so that the sbi gene and truncates were
expressed from the anhydrotetracycline-inducible pro-
moter on the vector. The plasmids expressing full-length
Sbi and the C-terminal truncates Sbi1–335, Sbi1–368 and
Sbi1–403 were introduced into Newman Spa- Sbi-, bacteria
were grown in the presence of the inducer and cytoplasmic
membrane and culture supernatant fractions analysed by
SDS-PAGE and Western blotting. A 50 kDa band corre-
sponding to Sbi was detected in the membrane and super-
natant fractions of the strain expressing the wild-type Sbi.
The three truncates were detected in the culture superna-
tant, but in the case of the shortest, Sbi1–335, the protein was
not present in the membrane fraction and was only found
in the supernatant (Fig. 8D). This suggests that the
C-terminal domain Y is required to anchor the protein to
the membrane and that residues 335–368 are required
for efficient membrane anchoring but are not solely
responsible.
Why does Sbi occur extracellularly?
Given that recombinant MBP–Sbi protein binds to LTA
exposed on the bacterial cell surface it is perhaps surpris-
ing that Sbi can occur extracellularly unless the cell-bound
form saturates the surface-exposed LTA or the C-terminus
of the secreted form is modified so that it cannot recog-
nize LTA. To address this issue Newman Spa- Sbi+ and
Newman Spa- Sbi- cells were coated onto the surface
of ELISA wells and incubated with MBP–Sbi41–436 and
MBP–Sbi254–436. A reduction in absorbance of 2.3- and
3-fold occurred, respectively, when binding of MBP–Sbi to
the Sbi+ strain was compared with the Sbi- mutant
(Fig. 9A and B). This suggests that a significant fraction of
the LTA on the surface of Sbi+ cells is unavailable for
binding by the secreted form of Sbi.
Similar results were obtained when purified membranes
from Newman Spa- Sbi+ and Newman Spa- Sbi- cells
were immobilized and incubated with MBP–Sbi proteins,
with a 2.4-fold and 2.7-fold reduction in binding of
MBP–Sbi41–436 and MBP–Sbi254–436 respectively (Fig. 9C
and D). This suggests that a significant number of sites
were unavailable in the membrane material purified from
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the Sbi+ cells. To rule out the possibility that increased
binding by Sbi- cells and cytoplasmic membranes may be
due to increased production of LTA the amount of LTA in
Sbi+ and Sbi- cells was investigated by Western blotting
with anti-LTA serum. No difference in LTA expression was
seen between Sbi+ and Sbi- bacteria (data not shown).
Can the Sbi Y domain support binding to the
cytoplasmic membranes of other type I LTA
expressing strains?
The ability of Sbi to bind to membranes (presumably via
LTA) of other Gram-positive bacteria was investigated.
Cytoplasmic membrane material purified from S. aureus,
S. epidermidis, S. lugdunensis, L. monocytogenes and
the Gram-negative bacteria E. coli was incubated in
microtitre plates. The membranes were incubated with
either MBP–Sbi303–436 or MBP. MBP–Sbi303–436 bound the
cytoplasmic membranes of all five Gram-positive bacteria
with a similar affinity while the MBP control was unable to
bind (Fig. 10A). All five Gram-positive bacterial strains
tested express type I LTA which has a poly(glycerophos-
phate) backbone (Neuhaus and Baddiley, 2003). In con-
trast MBP–Sbi303–436 did not bind to the cytoplasmic
membrane material of E. coli which does not express LTA.
These results indicate that the C-terminal Y domain of Sbi
binds strongly to purified cytoplasmic membranes of
strains expressing LTA which has a poly(glycerophos-
Fig. 8. Cellular localization of Sbi C-terminal truncates.
A. Coomassie stain of an SDS-PAGE gel of MBP–Sbi303–436. Western immunoblot of MBP–Sbi303–436 probed with HRP-conjugated anti-MBP
IgG.
B. Binding of MBP–Sbi303–436 and MBP to plates coated in Newman Spa- Sbi- cytoplasmic membrane material.
C. Binding of MBP–Sbi254–436, MBP–Sbi303–436 and MBP to Newman Spa- Sbi- LTA-coated wells. Recombinant protein binding was detected with
HRP-conjugated anti-MBP IgG. Each assay was preformed n = 3 times with similar results. The graphs shown are representatives of one
experiment with each plot in the graph representing the average of duplicate wells.
D. Cytoplasmic membrane and culture supernatant fractions of Newman Spa- Sbi- (pRMC2-sbi ) C-terminal truncates analysed by Western
immunoblotting with HRP-labelled rabbit IgG.
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phate) backbone. Furthermore MBP–Sbi303–436 binding to
the cytoplasmic membranes of all four Gram-positive bac-
teria was inhibited by pre-incubating MBP–Sbi303–436 with
soluble purified LTA from S. aureus (Fig. 10B).
Discussion
The notion that the function of the Sbi protein is to help
protect S. aureus from innate immune defences of the
host was initially based on the in vitro activities of the
recombinant D1 and D2 domains that bind to the Fc
region of IgG and the D3 and D4 domains which can bind
to complement factor C3 in serum and can promote its
futile consumption (Zhang et al., 1998; 1999; Burman
et al., 2008). If Sbi protects cells in the same manner as
protein A by binding IgG at the Fc region so that the
immunoglobulin cannot act as an opsonin or promote
complement fixation, the protein must be bound to the cell
envelope with domains D1 and D2 exposed on the cell
surface. However, if domains D3 and D4 are to promote
futile consumption of C3 in the fluid phase they must do so
at a distance from the cell otherwise they would actually
promote opsonin formation. This requires the protein to be
secreted from the cell and for the D3D4 domains of the
cell-associated Sbi to be inactive.
We have recently shown that Sbi both is associated
with the cell envelope (where it is at least partly displayed
on the surface) and is also present extracellularly and that
both forms of the protein contribute to immune evasion
(Smith et al., 2011). Examination of the level of exposure
of Sbi on the surface of whole cells indicates that the
N-terminal D1 and D2 domains are available to bind IgG.
In contrast only a small proportion of the D3 and D4
domains are recognized by the Fab regions of anti-
D3D4WrY IgG.
The Sbi protein is attached to the cell envelope by an
unusual mechanism. When cells were converted to pro-
toplasts the cell-associated protein was not solubilized
like the LPXTG-anchored protein A or ClfA. Instead it
was attached to the cytoplasmic membrane fragments
Fig. 9. Binding of MBP–Sbi to whole cells and purified cytoplasmic membrane. Binding of MBP–Sbi41–436, MBP–Sbi254–436 MBP–Sbi41–253 and
MBP to wells coated with (A) S. aureus Newman Spa- Sbi+ cells, (B) Newman Spa- Sbi- cells, (C) Newman Spa- Sbi+ cytoplasmic membrane
material and (D) Newman Spa- Sbi- cytoplasmic membrane material. Closed symbols and black lines refer to Newman Spa-. Recombinant
protein binding was detected with HRP-conjugated anti-MBP IgG. Each assay was preformed n = 3 times with similar results. The graphs
shown are representatives of one experiment with each plot in the graph representing the average of duplicate wells. Blots shown are
representative of three independent experiments.
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following lysis of protoplasts and sedimentation. Purified
recombinant MBP–Sbi bound to immobilized membrane
fragments prepared from an Sbi- mutant. Finding that
recombinant Sbi bound to purified lipoteichoic acid both
dose-dependently and saturably suggests that LTA is the
ligand in the cell envelope bound by Sbi when it is
secreted across the membrane of growing cells. Also,
reaching saturation in the binding assays is important
because it is indicative of a specific interaction. Further-
more MBP–Sbi could not bind to purified cell wall
material.
In support of our contention that LTA is a ligand for
attaching Sbi to the cell envelope is (i) the specific binding
of rSbi both to purified LTA and to the membrane fraction,
(ii) inhibition of binding of rSbi to the membrane fraction by
soluble LTA, (iii) partial displacement of Sbi from the mem-
brane fraction by soluble LTA, (iv) binding of rSbi to the
surface of whole cells where LTA is known to be exposed,
(v) a reduction in the level of Sbi in the cytoplasmic mem-
brane of an LTA-negative mutant, and (vi) the ability to
bind to the membranes of other Gram-positive bacteria
with type I LTA in their cytoplasmic membranes. However,
LTA might not be the only ligand for Sbi in the membrane.
High concentrations of soluble LTA could only partially
displace bound Sbi. Figure 11 summarizes our current
understanding of the association of Sbi with the cell enve-
lope and its role in immune evasion. It shows membrane-
associated Sbi partially exposed on the cell surface with
the N-terminal D1D2 domains able to bind IgG. Extracel-
lular Sbi cannot attach to the cell because most of the LTA
is already occupied ensuring that at least some Sbi is
available and possibly triggers C3 metabolism as
described by Burman et al. (2008). The secreted form of
Sbi can also bind IgG but this does not provide any
protection from opsonophagocytosis (Smith et al., 2011).
The behaviour of Sbi in cell fractionation experiments and
its ability to bind to LTA resembles internalin B (InlB) of
L. monocytogenes (Jonquieres et al., 1999). InlB binds to
the human growth hormone receptor Met on mammalian
cells and triggers bacterial internalization by receptor-
mediated endocytosis (Mengaud et al., 1996; Braun et al.,
1998; Shen et al., 2000). In order to act as an invasin InlB
must be able to promote clustering of the Met receptor in
the host cell membrane and trigger the signalling that
leads to cytoskeletal rearrangements and endocytosis
(Niemann, 2011). The ability of a secreted protein to
perform this seems paradoxical until one considers the
role of heparin sulphate proteoglycans that are bound on
the surface of mammalian cells (Marino et al., 2002). HSP
is able to displace cell-associated InlB and to promote its
release from the cell surface. It does so by binding to the
GW repeats that contain the binding sites for LTA. It is
likely that HSP–InlB complexes cooperate to trigger Met
receptor clustering.
A major difference between the association of InlB and
Sbi with LTA is that the latter does not bind to HSPs in vitro
and cannot be displaced easily from the membrane. This
is likely to be due to the highly specific interaction that
occurs between Sbi and LTA whereas the binding of InlB
to LTA appears to be much weaker and is probably non-
Fig. 10. Binding of MBP–Sbi303–436 to the cytoplasmic membranes of Gram-positive bacteria.
A. Cytoplasmic membrane material purified from S. aureus, S. epidermidis, S. lugdunensis, L. monocytogenes and E. coli were incubated with
MBP–Sbi303–436 and MBP in microtitre plates. Recombinant protein binding was detected with HRP-conjugated anti-MBP IgG.
B. Recombinant MBP–Sbi303–436 was pre-incubated with increasing concentrations of either S. aureus LTA or bovine serum, albumin (BSA)
(0–200 mg ml-1) before being added to cytoplasmic membrane-coated microtitre plates. Recombinant protein binding was detected with
HRP-conjugated anti-MBP IgG.
Each assay was preformed n = 3 times with similar results. The graphs shown are representatives of one experiment with each plot in the
graph representing the average of duplicate wells.
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specific and based on binding of GW repeats to highly
negatively charged polymers.
In conclusion Sbi is an immune evasion protein that
helps S. aureus to evade neutrophil-mediated phagocyto-
sis in human blood. It is present both in the medium and
in the cell envelope where it is displayed on the surface of
the bacterium. Both the secreted and cell-bound forms of
Sbi are required for full protection. The association of Sbi
with the cell envelope involves a specific interaction with
LTA and possibly another component of the membrane.
Experimental procedures
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table S1. S. aureus was routinely grown on tryptic soy agar
(TSA) or broth (TSB) at 37°C with shaking. E. coli strains
were grown on L agar (Difco) or in L broth at 37°C with
shaking. Antibiotics (Sigma) were added as required:
chloramphenicol (Cm) at 10 mg ml-1, erythromycin (Em) at
10 mg ml-1, tetracycline (Tc) at 2 mg ml-1, kanamycin (Ka) at
50 mg ml-1 and ampicillin (Ap) at 100 mg ml-1.
Isolation of an sbi mutant by allelic replacement
To inactivate the sbi gene, DNA fragments comprising 900 bp
upstream and 740 bp downstream of sbi were amplified by
PCR from genomic DNA and cloned together with an ermC
cassette (from pTSermC) between the HindIII and BamHI
sites of plasmid pBluescript. The construct was then ligated to
pTStetK, a plasmid that is temperature sensitive for replica-
tion in S. aureus, and the resulting chimeric plasmid was
designated pES2. pES2 was electroporated into S. aureus
strain RN4220 then transferred into S. aureus Newman to
achieve integration of the ermC gene into the genome by
homologous recombination by selecting on agar containing
Em at 43°C. After several cycles of growth in broth at 28°C
and at 43°C colonies were selected on Em agar and tested
for loss of Tcr. The sbi mutation was validated by PCR and
Western immunoblotting.
Cell fractionation
Solubilized cell wall proteins were obtained as follows. Bacte-
rial cultures of S. aureus, S. epidermidis and S. lugdunensis
were harvested by centrifugation at 2000 g for 10 min at 4°C,
washed in phosphate-buffered saline (PBS) and resuspended
Fig. 11. Proposed model for Sbi cellular localization and surface expression. The diagram shows Sbi binding to LTA and to a putative second
membrane component (X). Only one face of the lipid bilayer is shown. For LTA the jagged line represent polyglycerol phosphate repeats and
the diamond the disaccharide linker. The IgG-binding domains D1D2 are biologically active when Sbi is associated with the cell membrane.
Whereas D3D4 are biologically active only when secreted. The wall-anchored proteins Spa and ClfA are shown for context.
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in 1/20 volume of protoplast buffer [50 mM Tris-HCl, 20 mM
MgCl2, 30% (w/v) raffinose, pH 7.5] containing complete mini
EDTA-free protease inhibitors (Roche). Cell wall proteins were
solubilized by digestion with lysostaphin (200 mg ml-1) at 37°C
for 15 min. Protoplasts were harvested by centrifugation at
6000 g for 15 min and the supernatant was retained as the cell
wall fraction. Protoplasts were sedimented by centrifugation at
6000 g and resuspended in protoplast buffer with protease
inhibitors. Protoplast pellets were washed once and resus-
pended in ice-cold 50 mM Tris-HCl, pH 7.5 containing pro-
tease inhibitors and DNase (80 mg ml-1). Protoplasts were
lysed on ice by vortexing. The membrane fraction was
obtained by centrifugation at 40 000 g for 1 h at 4°C. The
supernatant was retained as the cytoplasm fraction. The pellet
was washed once with ice-cold lysis buffer and finally resus-
pended in 50 mM Tris-HCl, pH 7.5. The culture supernatant
was filtered through a 0.45 mm filter and proteins were precipi-
tated by addition of a 1:20 volume of ice-cold 100% w/v
trichloroacetic acid (TCA).
Listeria monocytogenes cytoplasmic membranes were
isolated by the same method as described above with the
following additions. Bacterial cultures were harvested by cen-
trifugation at 2000 g for 10 min and cells were washed twice in
PBS. An OD600 of 10 was resuspended in 250 ml of digestion
buffer (20 mM Tris-HCl, 10 mM MgCl2, 500 mM sucrose,
pH 7.5). Complete EDTA-free protease inhibitor cocktail (70 ml
of a 10¥ stock), mutanolysin (1000 U ml-1) and lysozyme
(1 mg ml-1) were added to the cells and incubated at 37°C for
20 min. Protoplasts were harvested by centrifugation at
3500 g for 15 min. Cell envelope material from E. coli was
isolated as follows. Cultures were harvested by centrifugation
at 2000 g for 10 min and cells were washed twice in PBS. An
OD600 of 10 was resuspended in 10 ml of PBS containing
protease inhibitors (Roche), lysozyme (200 mg ml-1) and
DNase (3 mg ml-1) and allowed to stand on ice for 1 h. Cells
were lysed by repeated passage through a French Pressure
Cell. The lysate was centrifuged at 20 000 g for 15 min at 4°C
in a Sorvall SS-34 rotor and the pellet was retained as the cell
envelope fraction. The pellet was washed once with ice-cold
lysis buffer and the pellet containing the cell envelope fraction
was finally resuspended in 1 ml of ice-cold lysis buffer.
SDS-PAGE
Protein samples were diluted in final sample buffer [125 mM
Tris-HCl, pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol, 10% (v/v)
b-mercaptoethanol and 0.002% (w/v) bromophenol blue] and
boiled for 5 min. Samples were loaded onto acrylamide gels
(3% stacking and 12% separating gel) and separated by
electrophoresis (Laemmli, 1970) at 120 V after which proteins
were visualized by Coomassie blue staining or electroblotted
onto PVDF membranes (Roche) for Western immunoblotting.
Western immunoblotting
Proteins were electroblotted onto PVDF membranes (Roche)
for 1 h at 100 V using a wet transfer cell (Bio-Rad). Mem-
branes were incubated for 1 h at 4°C in TS buffer (10 mM
Tris-HCl, pH 7.4, 150 mM NaCl) containing 10% (w/v)
skimmed milk (Marvel) (Marvel TS). Next, horseradish
peroxidise-conjugated antibodies or primary antibodies
diluted in Marvel TS were incubated with the membranes for
1 h at room temperature with shaking. Unbound antibody was
removed by three 10 min washes with TS buffer containing
0.01% Tween. Where necessary secondary antibodies (HRP-
conjugated) diluted in Marvel TS were then incubated with
the membranes for 1 h at room temperature with shaking.
Unbound secondary antibody was removed by washing three
times with 0.05% Tween/TS buffer and developed with chemi-
luminescent substrate LumiGlo (New England Biolabs). Blots
were exposed to X-Omat autoradiographic film (Kodak).
Whole-cell immunoblots
Cells were washed twice in PBS and adjusted to an OD600 of
1. Doubling dilutions (5 ml) were dotted onto a nitrocellulose
membrane (Protran). The membrane was blocked for 1 h with
Marvel TS. Specific anti-Sbi D3D4WrY serum was diluted in
Marvel TS buffer and incubated with the membrane for 1 h at
room temperature with shaking and washed three times with
TS buffer to remove unbound antibody. The secondary anti-
body was HRP-labelled goat anti-rabbit IgG. The membrane
was developed in the dark using the chemiluminescent sub-
strate LumiGlo (New England BioLabs)
Anti-Sbi serum
Antibodies were raised in specific pathogen free rabbits to
recombinant Sbi153–436 and the immunoglobulin fraction was
purified. Antibodies to recombinant Sbi153–436 were affinity-
purified to remove antibodies that cross-reacted with other
S. aureus proteins.
Construction of Sbi C-terminal truncates
pRMC2 plasmids that expressed N-terminal and C-terminal
truncates of Sbi were generated by PCR. Amplimers were
cloned between the KpnI and BglII sites in pRMC2 to create
pRMC2-sbi1–335, pRMC2-sbi1–368, pRMC2-sbi1–403 and pRMC2-
sbiDD1D2.
Expression and purification of recombinant
MBP-tagged Sbi
For expression of recombinant Sbi, pMAL-c2G constructs
were purified from E. coli XL1-Blue and transformed into
E. coli TB1 cells. Overnight cultures (20 ml) were inoculated
into fresh medium (1:50) and grown to an OD600 of 0.5. IPTG
was added to a concentration of 1.5 mM and the culture was
grown for a further 3 h. Cells were harvested by centrifuga-
tion at 7000 g for 10 min at 4°C. The pellet was resuspended
in PBS containing protease inhibitor (Roche), lysozyme
(200 mg ml-1) and DNase I (3 mg ml-1) and allowed to stand on
ice for 1 h. Cells were lysed by repeated passage through a
French Pressure Cell. Cell debris was removed by centrifu-
gation at 7000 g for 30 min at 4°C and the supernatant fil-
tered through a 0.45 mm filter. The MBP-fusion proteins were
purified using an amylose column (Bio-Rad). Proteins were
eluted using 10 mM maltose in amylose column buffer and
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samples were analysed by SDS-PAGE for presence of the
recombinant protein. Positive fractions were pooled and
dialysed against PBS. Recombinant MBP-fusion proteins had
approximate Mws ranging from 86 kDa (Sbi41–436) to 66 kDa
(Sbi41–253 and Sbi254–436). Protein concentrations were deter-
mined using the BCA protein assay kit (Pierce) according to
the manufacturer’s protocol.
Enzyme-linked immunosorbent assay (ELISA)
Nunc Maxisorp Immunoplates were coated with OD600 10 of
purified cytoplasmic membrane or whole cells of S. aureus
overnight at 4°C in 50 mM sodium carbonate buffer pH 9.6.
Coating was verified with anti-EbpS and anti-ClfA antibodies
respectively. Wells were blocked with 5% BSAin PBS for 2 h at
37°C. Between each, wells were washed 3¥ with PBS.
Increasing concentrations (0–12 mM) of recombinant Sbi41–436,
Sbi41–253 and Sbi254–436 proteins were added to coated wells for
2 h at 37°C and detected with HRP-conjugated anti-MBP IgG
(Bio Labs) and 3,3′, 5,5′-tetramethylbenzidine (TMB), the
reaction was stopped with 2 M H2SO4 and the results read at
450 nm.
Plates were coated with 5 mM LTA (Sigma) overnight at 4°C
in 50 mM sodium carbonate buffer pH 9.6. Coating A was
verified with an LTA-specific monoclonal antibody. Wells were
blocked with 5% BSA in PBS for 2 h at 37°C. Between each
step wells were washed 3¥ with PBS. Increasing concen-
trations (0–12 nM) of recombinant Sbi41–436, Sbi41–253 and
Sbi254–436 proteins were added to coated wells for 2 h at 37°C
and detected as described above. Half maximum binding
concentrations were calculated using GraphPad Prism
version 4.00 for Windows, GraphPad Software, San Diego,
California, USA. ELISA-type binding graphs shown through-
out this article are graphs of individual experiments that are
representative of three independent experiments. Each plot
represents the average of duplicate or triplicate wells. Half
maxima values represent the mean of three independent
experiments  standard deviation.
Cell wall preparation
Cells from a stationary-phase culture of strain Newman Spa-
Sbi- were adjusted to an OD600 100 in PBS and were resus-
pended in 1.5 ml of lysis buffer containing protease inhibitors,
DNase and RNase (80 mg ml-1). The cell suspension was
transferred to a blue cap FastRNA tube and shaken in a
Fastprep™ cell disrupter at speed 6 for 40 s. This was
repeated 12 times with cooling on ice for 1 min between
cycles. Cell lysis was monitored by phase-contrast
microscopy. Lysates were then centrifuged for 2 min at
3000 g to pellet any remaining whole cells. The supernatant
containing the cell wall fragments was boiled in 4% SDS for
2 h to remove cytoplasmic and membrane contaminates and
then washed in deionized water to remove SDS. The result-
ing lysates were centrifuged for 15 min at 15 000 g to sedi-
ment the cell wall fragments.
Inhibition of Sbi binding to purified cytoplasmic
membrane and immobilized LTA with LTA
Nunc Maxisorp Immunoplates were coated with OD600 10 of
purified cytoplasmic membrane or LTA (5 mM) overnight at
4°C in 50 mM sodium carbonate buffer pH 9.6. Wells were
blocked with 5% BSA in PBS for 2 h at 37°C. Between each
step wells were washed 3¥ with PBS. Recombinant MBP
Sbi41–436, Sbi41–253 and Sbi254–436 proteins were incubated
with increasing concentrations of LTA or heparin sulphate
(0–200 mg ml-1) for 1 h at 37°C before being added to coated
wells for 2 h at 37°C. MBP protein binding was detected as
described above.
Fractionation of exogenously added recombinant Sbi
with the cytoplasmic membrane
Newman Spa- Sbi- cells (OD600 = 5) were washed twice in
PBS and incubated in PBS with 5 mg ml-1 of each recombi-
nant protein Sbi41–436, Sbi41–253 and Sbi254–436 for 1 h at 37°C.
Bacteria were pelleted by centrifugation for 5 min at 14 000 g.
Cell fractionation was repeated as described above. Equiva-
lent amounts of material separated by 10% SDS-PAGE
and probed with HRP-conjugated anti-MBP antibodies and
detected as described above.
Displacement of Sbi from the cytoplasmic membrane
with LTA
Cytoplasmic membrane fractions of Newman spa were pre-
pared as described above and a sample (OD600 1) was incu-
bated in PBS with various concentrations of S. aureus LTA
(0–400 mg ml-1) for 1 h at 37°C and then pelleted by centrifu-
gation 40 000 g for 1 h at 4°C. The pellets were resuspended
in 50 mM Tris-HCl, pH 7.5. The supernatants were filtered
through a 0.45 mm filter and proteins were concentrated by
addition of a 1:20 volume of ice-cold 100 w/v TCA.
Far Western blotting of S. aureus cytoplasmic
membrane fractions with LTA
Cytoplasmic membrane fractions of Newman spa were pre-
pared as described above. Proteins were electroblotted onto
PVDF membranes (Roche) for 1 h at 100 V using a wet
transfer cell (Bio-Rad). Membranes were blocked with Marvel
TS and incubated with 2.5 mg ml-1 LTA in TS/Marvel for 1 h at
room temperature. Between each subsequent step mem-
branes were washed 3¥ in TS/with Tween 0.05%. Bound LTA
was detected with an LTA (polyglycerolphosphate)-specific
monoclonal antibody (clone 55, HyCult Biotechnology) fol-
lowed by HRP-linked anti-mouse IgG (Cell Signalling).
Purification of lipoteichoic acid from S. aureus
Lipoteichoic acid was isolated from S. aureus strain RN4220
as described previously (Grundling and Schneewind, 2007).
Purity was confirmed by NMR analyses.
Densitometric analysis
Densitometric analysis was carried out using ImageJ software
from the National Institute of Health (NIH). Integrated band
densities were measured with correction for background.
Values shown are the means of three independent
experiments  the standard deviation.
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